Investigation of the physiological effects of CXCR4 inhibition on the kinetics of radiolabelled neutrophils in man (EPIGRAPH)

Trial Profile

Investigation of the physiological effects of CXCR4 inhibition on the kinetics of radiolabelled neutrophils in man (EPIGRAPH)

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 28 Jun 2016

At a glance

  • Drugs Plerixafor (Primary)
  • Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Glioma; Sickle cell anaemia; Stem cell mobilisation
  • Focus Pharmacodynamics; Pharmacokinetics
  • Acronyms EPIGRAPH
  • Most Recent Events

    • 28 Jun 2016 New trial record
    • 13 Jun 2016 Planned End Date changed from 1 Oct 2017 to 1 May 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top